Td Ameritrade Investment Management, LLC Dexcom Inc Transaction History

Td Ameritrade Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $2,065 - $3,310	-24 Closed	0 $0
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $1,012 - $1,178	-9 Reduced 27.27%	24 $3,000
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $1,104 - $1,594	13 Added 65.0%	33 $4,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1,297 - $1,601	-17 Reduced 45.95%	20 $2,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $1,767 - $3,455	26 Added 236.36%	37 $3,000
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $1,428 - $1,791	11 New	11 $6,000
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $533 - $715	-5 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $404 - $539	5 New	5 $2,000
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $2,839 - $3,969	-102 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $2,554 - $3,474	91 Added 827.27%	102 $12,000
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $296 - $411	11 New	11 $1,000

1,085

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.